Geron Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
GERN Nasdaq 2830 www.geron.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Geron Corporation

Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - Jun 1st, 2026 6:00 am
Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - May 19th, 2026 7:35 am
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 18th, 2026 2:01 pm
First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026 - May 12th, 2026 7:31 am
Is Geron (GERN) One of the Best US Stocks Under $5 to Buy? - May 11th, 2026 3:21 pm
A Look At Geron (GERN) Valuation After Q1 Results And Reaffirmed 2026 Guidance - May 8th, 2026 7:17 am
Geron Corporation (NASDAQ:GERN) Just Reported And Analysts Have Been Lifting Their Price Targets - May 8th, 2026 7:02 am
Geron Corporation Q1 2026 Earnings Call Summary - May 7th, 2026 6:30 am
Geron Q1 Earnings Call Highlights - May 6th, 2026 7:07 am
Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates - May 6th, 2026 6:25 am
Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights - May 6th, 2026 5:00 am
Geron Plans to Present at Upcoming Investor Conferences - May 5th, 2026 6:00 am
Geron Corporation (GERN) Appoints Timothy Williams as EVP, Chief Legal Officer - Apr 25th, 2026 3:06 pm
Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026 - Apr 22nd, 2026 5:00 am
Geron Adds Chief Legal Officer As Equity Ties To Execution Risk - Apr 14th, 2026 6:14 pm
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Apr 14th, 2026 2:05 pm
Geron Highlights RYTELO Launch, 2026 Revenue Outlook and Phase 3 Myelofibrosis Plans at Needham Conf - Apr 13th, 2026 7:32 pm
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary - Apr 13th, 2026 6:00 am
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference - Apr 6th, 2026 6:00 am
Geron Adds Biopharma Veterans As RYTELO Focus And Valuation Draw Attention - Mar 28th, 2026 11:03 pm